Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

UMA MAHADEVAN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1851355283
CMS profile
219636
Location
SAN FRANCISCO, CA

General Payments · PY2018–2024

$237,321.66

  • Reported across 170 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$26,135.80

20 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $9,717.90 7
Janssen Biotech, Inc. $7,200.00 2
Merck Sharp & Dohme Corporation $5,037.50 5
Celltrion USA Inc. $2,150.00 2
ABBVIE INC. $2,000.00 3
PFIZER INC. $30.40 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $26,193.65 38
PY2019 $25,357.06 24
PY2020 $28,305.00 12
PY2021 $25,880.00 16
PY2022 $64,193.64 32
PY2023 $41,256.51 28
PY2024 $26,135.80 20

Payment records · PY2024 (20)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $650.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1104925827 CMS
ABBVIE INC. $650.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 1104925831 CMS
ABBVIE INC. $700.00 05/28/2024 Consulting Fee Undisputed 01/23/2026 1104925835 CMS
Celltrion USA Inc. $150.00 05/19/2024 Food and Beverage Undisputed 01/23/2026 1075854723 CMS
Celltrion USA Inc. $2,000.00 05/31/2024 Honoraria Undisputed 01/23/2026 1075854725 CMS
Janssen Biotech, Inc. $3,600.00 01/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078330642 CMS
Janssen Biotech, Inc. $3,600.00 02/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1078332207 CMS
Merck Sharp & Dohme LLC $650.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 1141587456 CMS
Merck Sharp & Dohme LLC $975.00 05/06/2024 Consulting Fee Undisputed 01/23/2026 1141832757 CMS
Merck Sharp & Dohme LLC $1,950.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 1141587458 CMS
Merck Sharp & Dohme LLC $162.50 06/24/2024 Consulting Fee Undisputed 01/23/2026 1141832641 CMS
Merck Sharp & Dohme LLC $1,300.00 10/07/2024 Consulting Fee Undisputed 01/23/2026 1141587454 CMS
PFIZER INC. $30.40 07/02/2024 Education Undisputed 01/23/2026 1131564669 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.05 02/19/2024 Food and Beverage Undisputed 01/23/2026 1137627430 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,356.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 1137627434 CMS
Takeda Pharmaceuticals U.S.A., Inc. $77.30 11/20/2024 Travel and Lodging Undisputed 01/23/2026 1137627438 CMS
Takeda Pharmaceuticals U.S.A., Inc. $80.78 11/22/2024 Food and Beverage Undisputed 01/23/2026 1137627442 CMS
Takeda Pharmaceuticals U.S.A., Inc. $61.52 11/23/2024 Food and Beverage Undisputed 01/23/2026 1137627445 CMS
Takeda Pharmaceuticals U.S.A., Inc. $892.34 11/24/2024 Travel and Lodging Undisputed 01/23/2026 1137627449 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,223.91 11/24/2024 Travel and Lodging Undisputed 01/23/2026 1137627453 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.